There has long been a paradigm in oncology: the search for specific target molecules on tumor cells in order to eliminate them in a targeted manner. The biotech company Vidac Pharma is now pursuing a radically different path. Instead of flipping a single switch, the technology aims to reprogram the entire derailed metabolism of a cancer cell. The idea is to get the cell to behave normally again and ultimately initiate programmed cell death. This systemic approach could be a game changer, as it addresses a fundamental characteristic of almost all tumors.
News & Events